Sun Pharma rises 2.7% as it launches Leqselvi in US following settlement with Incyte, with analysts projecting $200-300 million revenue from the drug in 3-5 years
Tribunal hears NGO's plea on alleged non-disclosure by Smartworks in IPO documents; ruling may impact equity share sale and listing plans
Sebi executive director says AIFs must align with global ESG norms as 40 per cent of capital comes from foreign investors expecting high disclosure standards
Speaking at an event organised by IVCA Renewable Energy Summit 2025, Ruchi Chojer, Executive Director at Sebi, said that trust is the cornerstone of investment, and India has earned that trust